Trials / Sponsors / Neurodawn Pharmaceutical Co., Ltd.
Neurodawn Pharmaceutical Co., Ltd.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Y-4 to Treat the Postherpetic Neuralgia Postherpetic Neuralgia, Y-4, Pregabalin | Phase 2 | 2026-02-02 |
| Not Yet Recruiting | RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Transcranial Bone Marrow Injection, RK-4, Acute Large Hemispheric Infarction | Phase 1 / Phase 2 | 2025-09-20 |
| Not Yet Recruiting | Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects Pharmacokinetic Differences, Y-3, Saftey | Phase 1 | 2025-07-10 |
| Completed | Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants Pharmacokinetic Profiles, Y-3 for Injection, Drug-drug Interaction | Phase 1 | 2025-05-18 |
| Completed | A Phase 1 Study of Y-3 in US Healthy Volunteers. Safety, Tolerability, Pharmacokinetic Study in Healthy Volunteers | Phase 1 | 2025-02-04 |